Document Detail

Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
MedLine Citation:
PMID:  23370938     Owner:  NLM     Status:  Publisher    
OBJECTIVES: To evaluate the short- and medium-term results of prostatic arterial embolisation (PAE) for benign prostatic hyperplasia (BPH). METHODS: This was a prospective non-randomised study including 255 patients diagnosed with BPH and moderate to severe lower urinary tract symptoms after failure of medical treatment for at least 6 months. The patients underwent PAE between March 2009 and April 2012. Technical success is when selective prostatic arterial embolisation is completed in at least one pelvic side. Clinical success was defined as improving symptoms and quality of life. Evaluation was performed before PAE and at 1, 3, 6 and every 6 months thereafter with the International Prostate Symptom Score (IPSS), quality of life (QoL), International Index of Erectile Function (IIEF), uroflowmetry, prostatic specific antigen (PSA) and volume. Non-spherical polyvinyl alcohol particles were used. RESULTS: PAE was technically successful in 250 patients (97.9 %). Mean follow-up, in 238 patients, was 10 months (range 1-36). Cumulative rates of clinical success were 81.9 %, 80.7 %, 77.9 %, 75.2 %, 72.0 %, 72.0 %, 72.0 % and 72.0 % at 1, 3, 6, 12, 18, 24, 30 and 36 months, respectively. There was one major complication. CONCLUSIONS: PAE is a procedure with good results for BPH patients with moderate to severe LUTS after failure of medical therapy. KEY POINTS : • Prostatic artery embolisation offers minimally invasive therapy for benign prostatic hyperplasia. • Prostatic artery embolisation is a challenging procedure because of vascular anatomical variations. • PAE is a promising new technique that has shown good results.
Joao Martins Pisco; Hugo Rio Tinto; Luís Campos Pinheiro; Tiago Bilhim; Marisa Duarte; Lúcia Fernandes; José Pereira; António G Oliveira
Related Documents :
11071328 - Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy lea...
25054388 - Fluoroscopically guided infiltration of the cervical nerve root: an indirect approach t...
11499818 - Utility of endoscopic ultrasonography in endoscopic drainage of pancreatic pseudocysts ...
24316748 - A prospective study of venous hemodynamics and quality of live at least five years afte...
25201758 - Adherence to allergen immunotherapy improves when patients choose the route of administ...
23315398 - Combination of intermittent cyclical etidronate and hormone replacement therapy for pos...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-31
Journal Detail:
Title:  European radiology     Volume:  -     ISSN:  1432-1084     ISO Abbreviation:  Eur Radiol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-2-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114774     Medline TA:  Eur Radiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Interventional Radiology, Saint Louis Hospital, Lisbon, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Creatinine Normalization of Workplace Urine Drug Tests: Does It Make a Difference?
Next Document:  Letter to the Editor re: Are intravenous injections of contrast media really less nephrotoxic than i...